Sutro Biopharma, Inc.
STRO
$7.30
-$0.72-8.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.30% | -17.61% | -21.43% | -18.38% | -8.86% |
| Total Receivables | -50.97% | -41.02% | 57.40% | 29.47% | -4.24% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -42.72% | -25.63% | 39.76% | 63.74% | 3.20% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.38% | -19.41% | -16.28% | -15.39% | -8.50% |
|
|
|||||
| Total Current Assets | -21.38% | -19.41% | -16.28% | -15.39% | -8.50% |
| Net Property, Plant & Equipment | -10.50% | -9.86% | -7.78% | -5.67% | -4.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -5.51% | -3.71% | -88.26% | 0.01% | 37.93% |
| Total Assets | -20.09% | -18.38% | -16.99% | -14.30% | -7.61% |
|
|
|||||
| Total Accounts Payable | 63.28% | -47.33% | -21.91% | 68.52% | 2.14% |
| Total Accrued Expenses | -35.62% | 47.01% | -15.39% | -4.08% | 6.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.20% | 3.76% | 3.81% | 3.85% | 3.89% |
| Total Finance Division Other Current Liabilities | 107.00% | -85.61% | 12.65% | -2.93% | -1.96% |
| Total Other Current Liabilities | 107.00% | -85.61% | 12.65% | -2.93% | -1.96% |
| Total Current Liabilities | -3.17% | -44.20% | 0.87% | 0.46% | 1.00% |
|
|
|||||
| Total Current Liabilities | -3.17% | -44.20% | 0.87% | 0.46% | 1.00% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -15.91% | -15.38% | -13.03% | -11.25% | -9.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.18% | 4.05% | 2.83% | 1.76% | 2.33% |
| Total Liabilities | 0.84% | -15.20% | 1.35% | 0.59% | 1.11% |
|
|
|||||
| Common Stock & APIC | 0.20% | 0.62% | 0.67% | 0.71% | 0.92% |
| Retained Earnings | -6.50% | -1.33% | -9.65% | -10.14% | -7.33% |
| Treasury Stock & Other | 353.85% | -44.44% | -123.08% | -63.21% | 165.03% |
| Total Common Equity | -171.77% | -24.41% | -157.87% | -59.90% | -26.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -171.77% | -24.41% | -157.87% | -59.90% | -26.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -171.77% | -24.41% | -157.87% | -59.90% | -26.91% |
|
|
|||||